http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102250005-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_533d562d612753d3536d0f182d93a56d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-22 |
| filingDate | 2010-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36dc942cf3897a1bbe8f01eacbc5bd01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_075490001ea40917ea7640d489ae09df |
| publicationDate | 2011-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102250005-A |
| titleOfInvention | The preparation method of Alixipine |
| abstract | The invention relates to the field of preparation of chemical substances and medicines, in particular to a preparation method of elixipine. The preparation method is that oxcarbazepine reacts under the action of a chiral catalyst [MX 2 ((S)-xyl-SDP)((R, R)-DPEN)] to obtain elixipine, wherein [MX 2 ((S) -xyl-SDP)((R, R)-DPEN)] is mainly composed of chiral diphosphine ligand formula (a) compound, chiral nitrogen ligand formula (b) compound, metal salt catalyst (MX 2 (p- cymene)) coordination combination, Among them: R 1 , R 2 , R 3 , R 4 , R 5 are C 1 ~ C 6 alkyl or C 6 ~ C 10 aryl or hydrogen or -OR 6 ; R 6 is C 1 ~ C 6 C 6 -C 10 aryl or hydrogen; R 7 is C 6 -C 10 aryl or C 1 -C 6 alkyl; R 8 is C 6 -C 10 aryl or C 1 -C 6 alkyl or hydrogen; M is Ru, Rh, Ir, Fe, Co or Ni; X is halogen. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021073231-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110790708-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108752276-A |
| priorityDate | 2010-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.